[go: up one dir, main page]

EE200200412A - 3-aminokinasoliin-2,4-dioon kui antibakteriaalne agens - Google Patents

3-aminokinasoliin-2,4-dioon kui antibakteriaalne agens

Info

Publication number
EE200200412A
EE200200412A EEP200200412A EEP200200412A EE200200412A EE 200200412 A EE200200412 A EE 200200412A EE P200200412 A EEP200200412 A EE P200200412A EE P200200412 A EEP200200412 A EE P200200412A EE 200200412 A EE200200412 A EE 200200412A
Authority
EE
Estonia
Prior art keywords
aminoquinazoline
dione
antibacterial agent
antibacterial
agent
Prior art date
Application number
EEP200200412A
Other languages
English (en)
Estonian (et)
Inventor
Daniel Hollis Showalter Howard
Bird Paul
Lee Ellsworth Edmund
Quoc Nguyen Dai
Peter Sanchez Joseph
Singh Rajeshwar
Andrew Stier Michael
Phong Tran Tuan
Morgan Watson Brian
Yip Judy
Original Assignee
Warner-Lambert Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner-Lambert Company filed Critical Warner-Lambert Company
Publication of EE200200412A publication Critical patent/EE200200412A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Paper (AREA)
EEP200200412A 2000-01-24 2000-12-12 3-aminokinasoliin-2,4-dioon kui antibakteriaalne agens EE200200412A (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17825200P 2000-01-24 2000-01-24
US24126700P 2000-10-18 2000-10-18
PCT/US2000/033656 WO2001053273A1 (en) 2000-01-24 2000-12-12 3-aminoquinazolin-2,4-dione antibacterial agents

Publications (1)

Publication Number Publication Date
EE200200412A true EE200200412A (et) 2003-10-15

Family

ID=26874138

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200412A EE200200412A (et) 2000-01-24 2000-12-12 3-aminokinasoliin-2,4-dioon kui antibakteriaalne agens

Country Status (38)

Country Link
US (2) US7094780B1 (xx)
EP (1) EP1255739B1 (xx)
JP (1) JP4811978B2 (xx)
KR (1) KR20020067701A (xx)
CN (1) CN1425008A (xx)
AP (1) AP2002002603A0 (xx)
AR (1) AR030186A1 (xx)
AT (1) ATE398110T1 (xx)
AU (1) AU783078B2 (xx)
BG (1) BG107023A (xx)
BR (1) BR0017010A (xx)
CA (1) CA2393802C (xx)
CO (1) CO5320600A1 (xx)
CR (1) CR6709A (xx)
DE (1) DE60039194D1 (xx)
EA (1) EA005585B1 (xx)
EE (1) EE200200412A (xx)
ES (1) ES2304992T3 (xx)
GE (1) GEP20053429B (xx)
HK (1) HK1054237A1 (xx)
HN (1) HN2001000009A (xx)
HR (1) HRP20020696A2 (xx)
HU (1) HUP0204101A3 (xx)
IL (1) IL150393A0 (xx)
IS (1) IS6448A (xx)
MA (1) MA26866A1 (xx)
MX (1) MXPA02005989A (xx)
NO (1) NO20023516L (xx)
OA (1) OA12316A (xx)
PA (1) PA8510101A1 (xx)
PE (1) PE20011060A1 (xx)
PL (1) PL356837A1 (xx)
SK (1) SK10572002A3 (xx)
SV (1) SV2001000288A (xx)
TN (1) TNSN01011A1 (xx)
UY (1) UY26551A1 (xx)
WO (1) WO2001053273A1 (xx)
YU (1) YU55902A (xx)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR013493A1 (es) 1997-09-15 2000-12-27 Procter & Gamble COMPUESTO DE QUINOLONA, SU USO PARA LA FABRICACIoN DE UN MEDICAMENTO Y COMPOSICIoN FARMACEUTICA QUE LO COMPRENDE
BR0210099A (pt) 2001-05-30 2004-04-13 Warner Lambert Co Agentes antibacterianos
MXPA03009894A (es) * 2001-06-19 2004-02-17 Warner Lambert Co Agentes antibacterianos.
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
WO2005026153A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinazoline-2, 4-diones as antibacterial agents
BRPI0414319A (pt) * 2003-09-12 2006-11-07 Warner Lambert Co agentes antibacterianos de quinolona
EP1687296A1 (en) * 2003-11-18 2006-08-09 Warner-Lambert Company LLC Antibacterial aminoquinazolidinedione derivatives
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
GB0416730D0 (en) 2004-07-27 2004-09-01 Novartis Ag Organic compounds
CA2595605A1 (en) * 2005-01-26 2006-08-03 F. Hoffmann-La Roche Ag Phenyl methanone derivatives and their use as glycine transporter 1 inhibitors
GB0507298D0 (en) * 2005-04-11 2005-05-18 Novartis Ag Organic compounds
US7977346B2 (en) 2006-01-17 2011-07-12 Guoqing Paul Chen Spiro compounds and methods of use
KR20110082635A (ko) 2006-03-28 2011-07-19 워너 칠콧 컴퍼니 엘엘씨 퀴놀론 중간체를 제조하기 위한 커플링 방법
PL2001862T3 (pl) 2006-03-28 2011-09-30 Warner Chilcott Co Llc Jabłczany oraz odmiany polimorficzne kwasu (3S,5S)-7-[3-amino-5-metylo-piperydynylo]-1-cyklopropylo-1,4-dihydro-8-metoksy-4-okso-3-chinolinokarboksylowego
US20080139574A1 (en) 2006-11-30 2008-06-12 Cadila Healthcare Limited Novel quinoline derivatives
ES2387539T3 (es) * 2008-01-30 2012-09-25 Shin Poong Pharmaceutical Co. Ltd. Nuevo derivado de quinazolina-2,4-diona, y composiciones para la profilaxis y tratamiento de enfermedades nerviosas craneales conteniendo el mismo derivado
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
US8754114B2 (en) 2010-12-22 2014-06-17 Incyte Corporation Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
AR085806A1 (es) 2011-03-15 2013-10-30 Trius Therapeutics Inc Inhibidores triciclicos de girasa
KR102032934B1 (ko) * 2011-12-21 2019-10-16 지앙수 헨그루이 메디슨 컴퍼니 리미티드 피롤 6원 헤테로아릴 고리 유도체, 그의 제조 방법, 및 그의 의약 용도
DK3176170T3 (en) 2012-06-13 2019-01-28 Incyte Holdings Corp SUBSTITUTED TRICYCLIC RELATIONS AS FGFR INHIBITORS
US9388185B2 (en) 2012-08-10 2016-07-12 Incyte Holdings Corporation Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
WO2014043272A1 (en) 2012-09-12 2014-03-20 Trius Therapeutics Inc. Tricyclic gyrase inhibitors for use as antibacterial agents
US9266892B2 (en) 2012-12-19 2016-02-23 Incyte Holdings Corporation Fused pyrazoles as FGFR inhibitors
CA3130452C (en) 2013-04-19 2023-10-31 Incyte Holdings Corporation Bicyclic heterocycles as fgfr inhibitors
US10851105B2 (en) 2014-10-22 2020-12-01 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
MX373169B (es) 2015-02-20 2020-04-24 Incyte Holdings Corp Heterociclos bicíclicos como inhibidores de receptores del factor de crecimiento fibroblástico (fgfr).
MA41551A (fr) 2015-02-20 2017-12-26 Incyte Corp Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
US9580423B2 (en) 2015-02-20 2017-02-28 Incyte Corporation Bicyclic heterocycles as FGFR4 inhibitors
CN108530448A (zh) * 2017-03-02 2018-09-14 浙江司太立制药股份有限公司 含有碱性氮杂螺环片段的苯并噻嗪-4-酮类化合物及其制备方法
AR111960A1 (es) 2017-05-26 2019-09-04 Incyte Corp Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
CN112867716B (zh) 2018-05-04 2024-09-13 因赛特公司 Fgfr抑制剂的固体形式和其制备方法
AU2019262579B2 (en) 2018-05-04 2024-09-12 Incyte Corporation Salts of an FGFR inhibitor
CN111620866A (zh) * 2019-02-27 2020-09-04 南京药石科技股份有限公司 一种顺式-7,7-二氟-六氢-1H 吡咯并[3,4-c]吡啶衍生物及其制备方法
US11628162B2 (en) 2019-03-08 2023-04-18 Incyte Corporation Methods of treating cancer with an FGFR inhibitor
WO2021007269A1 (en) 2019-07-09 2021-01-14 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
US12122767B2 (en) 2019-10-01 2024-10-22 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
PH12022550892A1 (en) 2019-10-14 2023-05-03 Incyte Corp Bicyclic heterocycles as fgfr inhibitors
US11566028B2 (en) 2019-10-16 2023-01-31 Incyte Corporation Bicyclic heterocycles as FGFR inhibitors
CA3162010A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Derivatives of an fgfr inhibitor
CA3163875A1 (en) 2019-12-04 2021-06-10 Incyte Corporation Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en) 2020-01-15 2021-07-22 Incyte Corporation Bicyclic heterocycles as fgfr inhibitors
CN111499513B (zh) * 2020-04-24 2023-03-14 上海毕得医药科技股份有限公司 一种2,3,4,5-四溴苯甲酸酯的合成方法
JP2024513575A (ja) 2021-04-12 2024-03-26 インサイト・コーポレイション Ｆｇｆｒ阻害剤及びネクチン－４標的化剤を含む併用療法
AR126102A1 (es) 2021-06-09 2023-09-13 Incyte Corp Heterociclos tricíclicos como inhibidores de fgfr

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (xx) * 1959-11-05
FR1203542A (fr) * 1958-02-25 1960-01-19 Rhone Poulenc Sa Nouveaux dérivés de la phénothiazine comportant en position 10 une chaîne pipérazinique et leurs procédés de préparation
EP0035619B1 (fr) 1980-03-10 1984-07-25 BERRI-BALZAC Société dite: Dérivés d'amino-3 (1H,3H) quinazolinedione-2,4
GB2097784A (en) 1981-04-28 1982-11-10 Davidson Dr John Stirton Dihydrobenzotriazepine diones; aminoquinazoline diones
AU5813394A (en) 1992-12-23 1994-07-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Anellated uracil derivates
AU6908398A (en) 1996-10-28 1998-05-22 Versicor Inc Fused 2,4-pyrimidinedione combinatorial libraries and biologically active fused 2,4-pyramidinediones
SI1028950T1 (en) * 1997-10-28 2003-08-31 Warner-Lambert Company Llc 7-substituted quinazolin-2,4-diones useful as antibacterial agents
EP1080092B1 (en) * 1998-05-26 2008-07-23 Warner-Lambert Company LLC Bicyclic pyrimidines and bicyclic 3,4-dihydropyrimidines as inhibitors of cellular proliferation
DE69927403T2 (de) * 1998-12-11 2006-07-06 F. Hoffmann-La Roche Ag Cyclische hydrazinderivate als tnf-alpha-inhibitoren

Also Published As

Publication number Publication date
NO20023516D0 (no) 2002-07-23
HUP0204101A2 (hu) 2003-04-28
AP2002002603A0 (en) 2002-09-30
DE60039194D1 (de) 2008-07-24
EP1255739A1 (en) 2002-11-13
GEP20053429B (en) 2005-01-25
NO20023516L (no) 2002-07-23
US7582627B2 (en) 2009-09-01
UY26551A1 (es) 2001-04-30
EA005585B1 (ru) 2005-04-28
CA2393802C (en) 2011-04-19
CO5320600A1 (es) 2003-09-30
US20060183762A1 (en) 2006-08-17
SK10572002A3 (sk) 2003-10-07
IS6448A (is) 2002-06-27
PL356837A1 (en) 2004-07-12
JP4811978B2 (ja) 2011-11-09
CR6709A (es) 2003-11-25
EP1255739B1 (en) 2008-06-11
MA26866A1 (fr) 2004-12-20
OA12316A (en) 2006-05-15
EA200200661A1 (ru) 2003-02-27
US20060287308A1 (en) 2006-12-21
KR20020067701A (ko) 2002-08-23
ES2304992T3 (es) 2008-11-01
PE20011060A1 (es) 2001-10-12
JP2003520277A (ja) 2003-07-02
CA2393802A1 (en) 2001-07-26
BG107023A (en) 2003-04-30
CN1425008A (zh) 2003-06-18
SV2001000288A (es) 2001-11-30
AU783078B2 (en) 2005-09-22
WO2001053273A1 (en) 2001-07-26
MXPA02005989A (es) 2002-10-23
ATE398110T1 (de) 2008-07-15
AR030186A1 (es) 2003-08-13
HRP20020696A2 (en) 2003-12-31
HK1054237A1 (zh) 2003-11-21
US7094780B1 (en) 2006-08-22
PA8510101A1 (es) 2003-06-30
HUP0204101A3 (en) 2004-05-28
TNSN01011A1 (en) 2005-11-10
IL150393A0 (en) 2002-12-01
AU2089901A (en) 2001-07-31
YU55902A (sh) 2006-01-16
BR0017010A (pt) 2002-11-05
HN2001000009A (es) 2001-06-13

Similar Documents

Publication Publication Date Title
EE200200412A (et) 3-aminokinasoliin-2,4-dioon kui antibakteriaalne agens
MXPA03000503A (es) Derivados de oxazolidinona como antimicrobianos.
PT1206469E (pt) Fenil-oxazolidinonas substituidas heterociclicas antibacterianas
DE60113450D1 (de) Antimikrobielle chinolone
NO20021183L (no) Antimikrobielle tilsetningsstoffer
PT1104420E (pt) 1-aril-3-arilmetil-1,8-naftiridin-4(1h)-onas
NO20015722L (no) Antibakterielle forbindelser
NO20015744D0 (no) Bredspektrede antimikrobielle blandinger
FI20002245L (fi) Antimikrobinen polyalfaolefiinikoostumus
NO20032122D0 (no) Forbedret behandling
DE50000423D1 (de) Sendeempfänger
EE200400004A (et) Oksasolidinoonide derivaadid kui antibakteriaalsed ained
NO20024745L (no) 2-hydroksymutilinkarbamat-derivater for antibakteriell anvendelse
DE60004207D1 (de) Bizyklische oxazolidinone als antibakterielle mittel
NO20020621D0 (no) Antibakterielle midler
DE60102936D1 (de) Antibakterielle mutiline
DE69943028D1 (de) CDMA-Empfänger
GB0118407D0 (en) Oxazolidinone derivatives as antibacterial agents
DE60135877D1 (de) Antibakterielle zusammensetzung
DK1206476T3 (da) 9a-azalider med antibakteriel virkning
DE50100739D1 (de) Drehmaschine
DE50209187D1 (de) Antibakterielle makrozyklen
DE60031472D1 (de) CDMA Empfänger
DE60017078D1 (de) Handfunkgerät
IS6626A (is) Kristallskenndur meðferðarmiðill